Lataa...
Use of magnesium as a drug in chronic kidney disease
From chronic kidney disease (CKD) Stage 4 onwards, phosphate binders are needed in many patients to prevent the development of hyperphosphataemia, which can result in disturbed bone and mineral metabolism, cardiovascular disease and secondary hyperparathyroidism. In this review, we re-examine the us...
Tallennettuna:
| Julkaisussa: | Clin Kidney J |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4455824/ https://ncbi.nlm.nih.gov/pubmed/26069822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndtplus/sfr168 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|